SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bal Pharma informs about board meeting

29 Jul 2022 Evaluate

Bal Pharma has informed that the meeting of Board of Directors of the Company is scheduled to be held on 11th August 2022 on Thursday to take on record and approve the Unaudited financial results of the Company for the quarter ended 30.06.2022. Further, pursuant to amended provisions of SEBI (Prohibition of Insider Trading Regulations),2015 and as per the provisions of Code of Conduct of the Company, the trading window for dealing in securities of the Company by its designated persons/employees and their ‘immediate relatives was closed from 01.07.2022 up to 14.08.2022 48 hours after declaration of financial results of the Company for the quarter ended 30.06.2022.

The above information is a part of company’s filings submitted to BSE.

Bal Pharma Share Price

78.47 0.00 (0.00%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×